). Both rs186019316 and rs7596758 or proxies are located in transcription factor binding regions. No significant association with rare variants was found in either the exons of TMEM18 or the 3ʹ genome-wide association study region. 
B
ody mass index (BMI), an important risk factor for diabetes mellitus and coronary heart disease, is a complex trait with variation attributable to both environmental and genetic factors. The heritability of BMI has been variously estimated between 25% and 75% overall, indicating a substantial genetic influence, 1 and both common and rare variants have been associated with BMI. Rare mutations have been identified in families with Mendelian forms of obesity, where family members carrying these highly penetrant rare variants typically demonstrate extreme obesity with early onset in childhood. [2] [3] [4] In the general population, the Genetic Investigation of Anthropometric Traits (GIANT) consortium identified 32 common variants, including loci FTO, TMEM18, and MC4R, 5 associated with BMI through genome-wide association studies (GWAS).
Although the large sample sizes of GWAS have identified loci strongly associated with BMI, together they explain <2% of the total variation in BMI. 5 The majority of variants identified by GWAS are not obviously functional, and associated variants may simply serve as markers for the underlying functional variants. This study evaluated the TMEM18 region (≈91 kb), including the TMEM18 gene and downstream, using targeted deep resequencing. Our study goals were (1) to localize functional variants in this region and (2) to determine whether low-frequency and rare functional variants contribute additionally to the genetic signal for BMI in this region. We chose this region for 2 reasons: first, it contains one of the primary replicated genome-wide signals for BMI; 5, 6 and second, the GWA signal is intergenic downstream (3ʹ) of the TMEM18 gene and, therefore, not covered by ongoing exome sequencing efforts in these populations. In addition, FTO is a well-established locus that has attracted the efforts of other groups such as Sällman Almén et al. 7 Considering the limited resources available for
Background-Genome-wide association studies for body mass index (BMI) previously identified a locus near TMEM18. We conducted targeted sequencing of this region to investigate the role of common, low-frequency, and rare variants influencing BMI. Methods and Results-We sequenced TMEM18 and regions downstream of TMEM18 on chromosome 2 in 3976 individuals of European ancestry from 3 community-based cohorts (Atherosclerosis Risk in Communities, Cardiovascular Health Study, and Framingham Heart Study), including 200 adults selected for high BMI. We examined the association between BMI and variants identified in the region from nucleotide position 586 432 to 677 539 (hg18). Rare variants (minor allele frequency, <1%) were analyzed using a burden test and the sequence kernel association test. Results from the 3 cohort studies were metaanalyzed. We estimate that mean BMI is 0.43 kg/m 2 higher for each copy of the G allele of single-nucleotide polymorphism rs7596758 (minor allele frequency, 29%; P=3.46×10 −4 ) using a Bonferroni threshold of P<4.6×10 −4 . Analyses conditional on previous genome-wide association study single-nucleotide polymorphisms associated with BMI in the region led to attenuation of this signal and uncovered another independent (r 2 <0.2), statistically significant association, rs186019316 (P=2.11×10 each phenotype group in CHARGE 8 Consortium Targeted Sequencing Study, we chose TMEM18 and its downstream region to maximize our contribution and impact on the field.
We used data from the CHARGE Targeted Sequencing Study, which completed targeted resequencing and analysis of 3976 individuals with BMI of European ancestry from 3 community-based cohorts: Atherosclerosis Risk in Communities (ARIC), Cardiovascular Health Study (CHS), and Framingham Heart Study (FHS).
Methods

Study Design and Samples
Briefly, the CHARGE Targeted Sequencing Study implemented a case-cohort study design, in which both a random sample of participants (cohort random sample) and participants with extreme values on 14 traits (14 phenotype groups) were selected from each of the 3 participating cohorts. 9 The phenotype group for the BMI trait included participants from each cohort who were selected as having the highest BMI levels for their sex and age (100 from ARIC, 50 from CHS, and 50 from FHS). Our analysis included the 194 participants selected on the basis of high BMI (1862 participants in other phenotype groups and 1920 participants from the cohort random sample; Table 1 ). In total, we analyzed 3974 individuals with available BMI measurements in the cohort random sample and phenotype groups (Table 1 ). To avoid confounding by race, all participants were of European ancestry. In addition, all participants in this study provided informed consent to their local institutions for the use of their genetic and other data. All studies were approved by the institutional review committee, and informed consent was obtained from subjects.
Sequence Data, Quality Control, and Bioinformatics for Functional Annotation
We used targeted resequencing, covering the region from 586 432 to 677 539 bp (hg18) and excluding regions with high guanine-cytosine content or which were highly conserved, for a total sequencing of 71 457 bp. Sequences were custom-captured by a NimbleGen Capture array and sequenced using the ABI SOLiD V4.0 platform. Sequence read alignment (mapping) was performed using the BLAST-like Fast Accurate Search Tool (BFAST) 10 algorithm, based on the hg18 reference genome (National Center for Biotechnology Information [NCBI] Genome Build 36). SAMtools 11 was used to convert the aligned read information into pileup data. The pileup results were filtered, producing variant calls, and annotated using the ANNOVAR 12 software package. Details are fully provided in a separate article. 9 Information for the resequenced region from Single Nucleotide Polymorphism Database build 135 was retrieved from the National Center for Biotechnology Information ftp site. 13, 14 Functional annotations from Single Nucleotide Polymorphism Database were parsed, and RsMergeArch was used to create mappings of all alias singlenucleotide polymorphism (SNP) identifiers. Regulatory variants were assessed using the current hg19 version of transcription factor binding sites from the Encyclopedia of DNA Elements (ENCODE) project, with positions translated to hg18. 15 These were determined by experiments using chromatin immunoprecipitation combined with next-generation sequencing technologies. Reported variants were confirmed using regulatory information from the HaploReg database. 16 
Statistical Approach
Details of the statistical approach are available elsewhere. 
Single Variant Analysis
We defined common variants as SNPs with ≥50 individuals carrying ≥1 minor allele among all participants sequenced; this was ≈1% allele frequency. For each common variant, we conducted an association analysis, using linear regression for ARIC and CHS samples and a linear mixedeffects model for related FHS samples, with BMI as the dependent variable, each single variant as the primary independent variable, and adjusting for sex, age, age 2 , study center, and principal components, as appropriate, to account for possible population stratification. Principal components were calculated using genome-wide genotype data within each cohort. We performed unweighted regression analyses to obtain P values for associations and weighted regression analyses to obtain effect estimates that accounted for the sampling design (Lumley T et al, unpublished data; http://stattech.wordpress.fos.auckland.ac.nz/files/2012/05/ design-paper.pdf). We applied a Bonferroni-corrected threshold to determine statistical significance of association for common variants, defined as 0.05 divided by the effective number of independent SNPs in the targeted region 17 : 4.6×10 −4 =0.05/108, where the effective number of independent SNPs out of 288 common variants is calculated based on the eigenvalues of the genetics correlation matrix proposed by Li and Ji. 17 We performed 2 conditional analyses: each added 1 of the 2 regional SNPs (rs6548238 and rs2867125) previously identified by GIANT *Examination 1 data were used for this analysis.
GWAS into the regression model as a covariate and tested all remaining regional SNPs for association. The interrogated region, near the TMEM18 gene, was first identified by the GIANT consortium in 2009, 6 and the lead SNP, rs6548238, is located 3ʹ of the gene at 624 905 bp (hg18), a region that contains no other genes. This finding was later confirmed by analysis of data from a larger group of studies in GIANT 5 with a different lead SNP, rs2867125 at 612 827 bp (hg18), which is in complete linkage disequilibrium with the SNP from the original report according to the HapMap CEU 1000G Pilot 1 data (r 2 and Dʹ=1). Additionally, we conditioned on an SNP identified in the unconditional analyses of these data and tested all remaining SNPs in the region.
Rare Variant Analysis
For variants with minor allele frequency <1%, we conducted analyses that collapsed or jointly modeled rare variants within our genomic region. Multiple variant tests have lower power to detect association when they include nonfunctional variants. 18, 19 Hence, we conducted rare variant analyses in 3 ways: the first included all rare SNPs, the second included all 10 rare nonsynonymous or splice site SNPs within TMEM18 exons, and the third included all 370 SNPs in the region located in transcription factor binding sites according to ENCODE criteria. 20 We used a T1 count test by analyzing the association of an aggregated statistic (the number of variants with ≥1 minor allele present). In addition, we conducted a sequence kernel association test (SKAT) to detect associations from variants with possibly different directions of effect.
Meta-Analysis
For single variant analysis of common SNPs and T1 analysis of rare SNPs, we performed fixed-effects, inverse-variance, weighted metaanalysis of study-specific association results to combine the association evidence across studies. For SKAT, we combined score and information components of the study-specific statistics to compute a combined SKAT statistic that adjusted for study. 
Results
We analyzed a total of 2180 variants, including 1629 novel variants not found in the 1000 Genomes Project, in or near TMEM18 with minor allele frequencies ranging from 0.0002 to 0.49 (Figure 1) . A total of 288 variants were considered to be common. The vast majority of the variants were intergenic. Of the 2180 investigated variants, 405 (35 common) were located in transcription factor binding regions assayed by chromatin immunoprecipitation combined with next-generation sequencing. In the subset of 288 common variants, there were 43 independent (r 2 <0.2) and nominally significant (P<0.05) SNPs associated with BMI, 8 of them in regulatory regions (Table I in the Data Supplement).
Single Variant Results
The SNPs previously reported by GIANT GWAS to be associated with BMI, 5, 6 rs6548238 and rs2867125, displayed nominally significant associations (P=0.007 and 0.039, respectively) associations with BMI in our data (Table 2; Figure 2 ). Our samples in this study are subsets of GIANT GWAS, and our results for these variants are consistent with those of GIANT, with the same direction of effect (C allele of each variant increasing BMI), and a greater magnitude of effect in our data (0.46 versus 0.26 for rs6548238 and 0.41 versus 0.31 in GIANT for rs2867125). 5, 6 Allele frequencies for these variants (18%) are similar in our data to those of GIANT (17% and 16%).
We identified another significantly associated variant in this region, rs7596758 (minor allele frequency, 28.8%; P=3.46×10 (Table 3 ) from a magnitude >0.4 to <0.1. In contrast, conditioning on either GIANT signal only modestly lowered the effect size of our top signal (rs7596758) from 0.43 to ≈0.30. Analysis conditional on rs2867125 also identified an additional significant variant, rs186019316 (P<4.6×10 −4 ; minor allele frequency, 2.2%), which is only weakly correlated with the GWAS SNPs and our top hit (rs7596758; r 2 <0.01 in ARIC data). None of the 287 additional common or low-frequency variants within the TMEM18 region, including coding or functional variants in TMEM18, were significantly associated with BMI.
Analysis of Rare Variants
The results from T1 count tests summarizing all rare SNPs and SKAT-based joint association of all rare SNPs for the TMEM18 region provide no support for an association between rare variants in the region and BMI (P=0.56 for T1; P=0.44 for SKAT). We also performed T1 and SKAT tests restricting to the 10 exonic functional (nonsynonymous or splice site) variants or the 370 SNPs localized within transcription factor binding sites in the TMEM18 
Discussion
This study aimed to finemap the previously identified GWAS signal near TMEM18 and to identify any independent variant(s) in the region using the targeted resequencing data. We found a cluster of associated SNPs, one of which (rs7596758) exceeded a Bonferroni-corrected statistical significance threshold of 4.6×10 −4 . Additional analyses conditioning on the previously reported associated SNPs in the region from GWAS identified another low-frequency variant (rs186019316). Both variants lie in transcription factor binding regions.
One possible limitation of our findings is the observed heterogeneity across the cohort samples and attenuated evidence of association in a random-effects meta-analysis (Table II in the Data Supplement). Age differences between the 3 participating cohorts may have potentially influenced our results. In support of this hypothesis, a growing literature has demonstrated age-specific differences in the magnitude of genetic associations. [21] [22] [23] [24] [25] For example, TMEM18 was reported to have larger BMI effect estimate in adolescents compared with adults. 23 On average, the participants in CHS (mean age, 72.5 years) are older compared with the 2 studies (FHS: 37.0 years; ARIC: 54.9 years) and displayed smaller genetic effect sizes.
Advances in genotyping technology and the development of novel, powerful analytic approaches have improved the accuracy and cost-effectiveness of testing variation in large samples, and these facilitated the present study. Here, we detected and verified genetic associations with BMI in a nonexonic region downstream of TMEM18 and extended our investigation to include low-frequency variants not represented in typical GWAS of common haplotypes. This study relies on the measurement of low-frequency variants using genetic resequencing. Studies that impute genotypes cannot readily examine low-frequency variant-disease associations, because imputation accuracy tends to be low for rarer variants. Furthermore, although many genetic association studies now concentrate on exonic variation, few focus on association in noncoding regions. Along with the significant progress made following up the 9p21 locus association with myocardial infarction and coronary artery calcification, our study's dual focus on noncoding variation and sequence variation in the region in and near TMEM18 proved fruitful. Regional association plot for the single variant analysis. The most significant variant, rs7596758, among a cluster of variants that are more significant than the Genetic Investigation of Anthropometric Traits (GIANT) hit (rs6548238 and rs2867125 with nominally significant P<0.05) is significant after adjusting for multiple testing. Single nucleotide polymorphism (SNP) rs186019316 is not significant with P=4.94×10 −4 in the single variant analysis but is significant in analysis conditioning on rs6548238 and rs2867125, respectively. MAF indicates minor allele frequency. 26 FOXA1 has been shown to play an important role in glucose homeostatis 27 and glucose-stimulated insulin secretion. 28 SNP rs186019316 lies in a putative binding region for repressor element-1 silencing transcription factor (REST), which represses the transcription of neuron-specific genes by binding the neuron-restrictive silencer element and restricting gene expression, 29, 30 but has not been reported to be related to adiposity biology. However, using Genomatix (Munich, Germany) to query predicted transcription factor binding motif alterations by these variants, we found no evidence that these variants alter the canonical binding motifs for FOXA1 or REST. The functional role of the reported SNPs needs to be further explored using in vitro experiments.
We demonstrate that for BMI, a complex quantitative trait, common variants downstream of TMEM18 may influence trait variation. Although these associations need to be confirmed, our findings add to the growing literature suggesting that GWAS signals tag regions where multiple single variants may be independently associated with the trait of interest. 31, 32 These may span the spectrum from low-frequency to common variants and increase the total variance of the trait that is explained by genetic variation. Indeed, the variants we found associated with BMI in the TMEM18 region differed with respect to their functional significance, effect size, and allele frequency.
This study has several notable strengths. It represents the first attempt to finemap the BMI-associated region near TMEM18 using a comprehensive resequencing approach in a large sample of subjects. Second, TMEM18 represents a region repeatedly shown to be associated with BMI. 5, 6, 23, 24 However, although our sample of ≈4000 is large for current sequencing studies, it is insufficient to detect small effects or individual associations with rare or low-frequency variants. Specifically, with a total sample size of 3976, we have the power of 51.38% to detect an effect size of 2.247, which is 0.1% of the variation in BMI, for a variant with minor allele frequency of 1%. Finally, although replication of our results would be desirable, because our focal region is not exonic, we know of no other studies with sequence data available for replication. Despite these limitations, our study does provide evidence for a possible regulatory role of this region with respect to adiposity.
In summary, our targeted resequencing study of the TMEM18 region of chromosome 2 reveals 2 variants associated with BMI, one of low frequency (2%) and the other common (29%). Our results indicate that conditioning on SNP rs7596758 (minor allele frequency, 29%) substantially weakens the estimated effects of variants previously identified by GIANT. Furthermore, our data provide no evidence that TMEM18-coding variants influence the phenotype. Instead, the data support a role for a region 3ʹ of the gene with annotated function that is likely to be regulatory. Expanded studies will be needed to characterize this region and its effects definitively.
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